Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Korro Bio, Inc. Director's Dealing 2024

Jun 12, 2024

33032_dirs_2024-06-12_33b79559-b171-4491-9875-33a424195bb9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Korro Bio, Inc. (KRRO)
CIK: 0001703647
Period of Report: 2024-06-11

Reporting Person: Lucchino David L. (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-06-11 Stock Option (Right to Buy) $42.19 A 5190 Acquired 2034-06-10 Common Stock (5190) Direct

Footnotes

F1: The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date.